Back to Trades
Total Value
$16.0K
Net $16.0K bought
Filing Date
Nov 20, 2025
1 transaction
Purchases
$16.0K
1 transaction
Trade Summary
On Nov 20, 2025, Rosenblum Mark J, Exec VP Finance, CFO, purchased $16.0K of Salarius Pharmaceuticals, Inc. (SLRX) across 1 transaction. The filing covers Common Stock and reflects net buying of $16.0K. Reported prices ranged from $0.80. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- Salarius Pharmaceuticals, Inc.
- Ticker Symbol
- SLRX
- CIK
- 0001615219
Insider Information
- Name
- Rosenblum Mark J
- Role
- Exec VP Finance, CFO
- Location
- HOUSTON, TX
Filing Details
- Filing Date
- Nov 20, 2025
- Transaction Date
- Nov 20, 2025
- Accession Number
- 0001615219-25-000177
- Form Type
- 4
- Net Trading Amount
- $16.0K
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Nov 20, 2025 | Common Stock | 20,000 | $0.80 | Purchase | $16.0K |
Want live alerts when Rosenblum Mark J trades again?
Download Insider Trades to track SLRX, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)Shares beneficially owned following the transaction is adjusted to reflect the reverse stock splits effective on June 16, 2024 and August 17, 2025.
- (F2)Includes 20 shares of unvested restricted stock granted on January 3, 2023.